Editor—The fraud committed by Dr John Anderton1 was not academic fraud, as in other recent cases, but financial fraud inspired by the large payments now made by drug companies to doctors to enter patients in trials. Within hospital departments this income is usually put into research funds, but in general practice the doctor is often personally remunerated. This is now sufficiently lucrative that some general practitioners have reduced their clinical work and set …